2023 Symposium Schedule
The Floyd A. Fried Advances in Urology Symposium will be held in-person at the Rizzo Center on June 23rd and 24th, 2022.
Friday, June 23, 2023
7:30 – 3:15pm EST
| Time | Presentation | Speaker(s) |
| 7:30 – 8:15am |
Registration & Continental Breakfast |
|
| 8:15 – 8:30am |
Welcome |
Drs. Matthew Nielsen & Marc Bjurlin |
| 8:30 – 9:00am | Immunotherapy Treatment of Prostate Cancer | Dr. Brian Miller |
| 9:00 – 9:30am | Keynote: Active Surveillance – Personalising the Pathway | Dr. Caroline Moore |
| 9:30 – 10:00am |
Break |
|
| 10:00 – 11:00am | Choose Your Technique: Robotic Radical Prostatectomy, a Video Walkthrough | Resident Video |
| 11:00 – 11:30am | Point-of-Care Germline Genetic Testing Through Interdisciplinary E-Consult | Ashlynn Messmore, MS, CGC |
| 11:30 – 12:30pm |
Lunch |
|
| 12:30 – 1:00pm | HoLEP for the Treatment of LUTS in Prostate Cancer | Dr. Gopal Narang |
| 1:00 – 1:30pm | Getting Men’s Mojo Back after Prostate Cancer Treatment | Dr. Marc Rogers |
| 1:30 – 1:45pm |
Break |
|
| 1:45 – 2:30pm | Keynote: Ten Years of MRI-Targeted Prostate Biopsy: Lessons Learned and Questions Remaining | Dr. Samir Taneja |
| 2:30 – 3:00pm | Pelvic radiation: The Trojan Horse for LUTS | Dr. Kristy Borawski |
| 3:00 – 3:15pm |
Adjourn |
Drs. Matthew Nielsen & Marc Bjurlin |
Saturday, June 24, 2023
8:00 – 12:15pm EST
| Time | Presentation | Speaker(s) |
| 8:00 – 8:25am |
Registration & Light Breakfast |
|
| 8:25 – 8:30am |
Welcome |
Drs. Matthew Nielsen & Marc Bjurlin |
| 8:30 – 9:00am | Prostate Cancer in Transgender Women | Dr. Brad Figler |
| 9:00 – 9:30am | Keynote: Managing Prostate Cancer Recurrence After Primary Therapy – a Paradigm in Evolution | Dr. Samir Taneja |
| 9:30 – 10:00am | Pelvic Fascia-sparing Robotic Prostatectomy – Fad or Future? | Dr. Ray Tan |
| 10:30 – 10:45am |
Brunch |
|
| 10:45 – 11:30am | Keynote: Focal Therapy – What Have We Learned in the Last 20 Years? | Dr. Caroline Moore |
| 11:30 – 12:00am | Local Therapy for Oligometastatic Prostate Cancer | Dr. Ari Wijetunga |
| 12:00 – 12:15pm |
Adjourn |
Drs. Matthew Nielsen & Marc Bjurlin |
Accreditation Statement
The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Statement
The School of Medicine of the University of North Carolina at Chapel Hill designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure statement
This activity has been planned and implemented under the sole supervision of the Course Director, Marc Bjurlin, DO, MSc, FACOS, in association with the UNC Office of Continuing Professional Development (CPD). The course director and CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME.
Dr. Borawski, Dr. Figler, Dr. Messmore, Dr. Narang, Dr. Rogers, Dr. Tan, Dr. Wijetunga, and the resident presenters have no relevant financial relationships with ineligible companies as defined by the ACCME.
Dr. Rogers received consulting fees from Boston Scientific (ended June 2022).
Dr. Miller receives consulting fees from Cellarity, Inc. Dr. Moore receives research support from SpectraCure and received speaking fees from Ipsen (ended June 2022) and proctoring fees from Sonablate (ended Jan 2023).
Dr. Taneja receives consulting fees from Exact Imaging, Francis Medical, Genomic Health, Imagin, Janssen, Lantheus, and Trod Medical, receives research support from MDx Health, and holds stock in Abbvie, Gilead, GT Biopharma, and Johnson and Johnson. These financial relationships were mitigated through slide review by UNC CPD.